Tedizolid, Faropenem, and Moxifloxacin Combination With Potential Activity Against Nonreplicating Mycobacterium tuberculosis

• Autori principali: Shashikant Srivastava (Autore), Kayle N. Cirrincione (Autore), Devyani Deshpande (Autore), Tawanda Gumbo (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2021-01-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Background:Mycobacteriumtuberculosis [Mtb] could be present in different metabolic population in the lung lesions, and nonreplicating persisters [NRP], associated with latent tuberculosis [TB], are the most difficult to kill.Objective: Test the combination of tedizolid, moxifloxacin, and faropenem f...